|
|
Ferric Chloride and Tannic Acid Treatment Enhance the Comprehensive Properties of Bovine Jugular Vein |
Wang Aili1, Zhou Jianye1*, Wang De1, Zhou Qingliang2, Wang Yumiao1, Huo Meijun2, Wang Yibo1 |
1(State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China) 2(Beijing Med Zenith Medical Scientific Co., Ltd, Beijing 101312, China) |
|
|
Abstract Glutaraldehyde (GA) cross-linked bovine jugular vein (BJV) is prone to calcification, which affects its wide clinical application. The addition of tannic acid (TA) treatment in combination with GA cross-linking has achieved excellent anti-calcification effect, however, with a deficiency of poor tissue compliance. As tannins can chelate with metal cations, this study used ferric ions (Fe3+) to interact with tannins to improve the comprehensive performance of TA treated BJV. In this study, the addition schemes of Fe3+ and reaction conditions such as pH were explored, the mechanical properties were examined by the uniaxial tensile test, the rat subcutaneous implantation model was used to determine the calcification level, and two-point bending method was used to test the flexibility. Vessels obtained from optimized treatment protocols were tested for biocompatibility. The results showed that under pH=8, the addition of Fe3+ before TA treatment improved the tissue compliance, and the flexibility was significantly improved compared with that of TA group, meanwhile, the mechanical strength was maintained. Calcium contents after subcutaneous implantation in rats were significantly lower than that in GA group [21d:(1.71±0.41) mg/g vs (38.12±7.40) mg/g, 60d:(2.73±1.13) mg/g vs(124.19±14.22) mg/g, P<0.05], and were equal to that of TA group (P>0.05). Moreover, the biocompatibility of theBJV met the requirements of implantable medical devices. This TA-Fe3+ treatment scheme is expected to be a new method for anti-calcification of BJV.
|
Received: 02 July 2022
|
|
Corresponding Authors:
* E-mail: zhoujy@263.net
|
|
|
|
[1] Ruzmetov M, Shah JJ, Geiss DM, et al. Decellularized versus standard cryopreserved valve allografts for right ventricular outflow tract reconstruction: a single-institution comparison[J]. J Thorac Cardiovasc Surg, 2012, 143(3):543-549. [2] Ross DN, Somerville J. Correction of pulmonary atresia with a homograft aortic valve[J]. Lancet, 1966, 31;2(7479):1446-1447. [3] Forbess JM. Conduit selection for right ventricular outflow tract reconstruction: contemporary options and outcomes[J]. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 2004, 7:115-124. [4] Willetts RG, Stickley J, Drury NE, et al. Four right ventricles to pulmonary artery conduit types[J]. J Thorac Cardiovasc Surg, 2021, 162(5):1324-1333. [5] Rastan AJ, Walther T, Daehnert I, et al. Bovine jugular vein conduit for right ventricular outflow tract reconstruction: evaluation of risk factors for mid-term outcome[J]. Ann Thorac Surg, 2006, 82(4):1308-1315. [6] Baslaim G. Bovine valved xenograft (contegra) conduit in the extracardiac Fontan procedure: the preliminary experience[J]. J Card Surg, 2008, 23(2):146-149. [7] Carrel T. Bovine valved jugular vein (contegra) to reconstruct the right ventricular outflow tract[J]. Expert Rev Med Devices, 2004, 1(1):11-19. [8] Li C, Xie B, Tan R, et al. Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction[J]. Front Bioeng Biotechnol, 2022,10:920152. [9] Protopapas AD, Athanasiou T. Contegra conduit for reconstruction of the right ventricular outflow tract: a review of published early and mid-time results[J]. J Cardiothorac Surg, 2008,18;3:62. [10] Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention[J]. Ann Thorac Surg, 2005,79(3):1072-1080. [11] Isenburg JC, Simionescu DT, Vyavahare NR. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall[J]. Biomaterials, 2005,26(11):1237-1245. [12] Isenburg JC, Simionescu DT, Vyavahare NR. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid[J]. Biomaterials, 2004,25(16):3293-3302. [13] Wang De, Zhou Jianye, Hu Shengshou, et al. Effect of tannic acid treatment on the physico-chemical properties of glutaraldehyde-fixed bovine jugular vein[J]. Acta Academiae Medicinae Sinica, 2009, 31(1): 65-67. [14] Zheng Xiaobing, Zhou Jianye, Wang De, et al. Study on the mechanism of tannic acid inducing bovine jugular vein cross-linking[J]. Chinese Journal of Biomedical Engineering, 2019, 38(6): 733-741. [15] Yang S, Wang Y, Wu X, et al. Multifunctional tannic acid (TA) and lysozyme (Lys) films built layer by layer for potential application on implant coating[J]. ACS Biomater Sci Eng, 2019, 5(7):3582-3594. [16] Véronique C, Rémi S, Jean-Michel S, et al. Comprehensive Natural Products II: Chemistry of Wine [M]. Amsterdam: Elsevier Press, 2010: 1119-1172. [17] Ejima H, Richardson JJ, Liang K, et al. One-step assembly of coordination complexes for versatile film and particle engineering[J]. Science, 2013, 341(6142):154-157. [18] Yang Liwei, Han Lulu, Ren Jun, et al. Coating process and stability of metal-polyphenol film[J]. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2015, 484:197-205. [19] Anshuman Shrivastava. Introduction to Plastics Engineering[M]. New York: William Andrew Publishing, 2018: 49-110. [20] Yan W, Shi M, Dong C, et al. Applications of tannic acid in membrane technologies: A review[J]. Adv Colloid Interface Sci, 2020, 284:102267. [21] Sathishkumar G, Gopinath K, Zhang K, et al. Recent progress in tannic acid-driven antibacterial/antifouling surface coating strategies[J]. J Mater Chem B, 2022, 10(14):2296-2315. [22] Guo Z, Xie W, Lu J, et al. Tannic acid-based metal phenolic networks for bio-applications: a review[J]. J Mater Chem B, 2021, 9(20):4098-4110. [23] Guo Y, Sun Q, Wu FG, et al. Polyphenol-Containing Nanoparticles: Synthesis, Properties, and Therapeutic Delivery[J]. Adv Mater, 2021, 33(22): e2007356. [24] Jin W, Guo G, Chen L, et al. Elastin stabilization through polyphenol and ferric chloride combined treatment for the enhancement of bioprosthetic heart valve anticalcification[J]. Artif Organs, 2018, 42(11):1062-1069. |
|
|
|